Los Angeles Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Los Angeles Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26,884	Closed	-$502K	–	1531
2022 Q1	$502K	Sell	26,884 -1,579	-6%	-$28.4K	﹤0.01%	1028
2021 Q4	$609K	Sell	28,463 -271	-0.9%	-$5.34K	﹤0.01%	914
2021 Q3	$531K	Buy	+28,734	New	+$579K	﹤0.01%	1021

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Los Angeles Capital Management's OCDX Position: Q2 2022 in Review

Los Angeles Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 26,884 shares — an estimated $502K sold.

Los Angeles Capital Management first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $609K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Los Angeles Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Los Angeles Capital Management sold 26,884 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $502K.
Los Angeles Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Los Angeles Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $609K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Los Angeles Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.